Evidence map›Paper›PMID 34511064›Full record

ArticleBMC public health2021

Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belém, Pará, Amazonia, Brazil.

Hilton Pereira da Silva, Isabella Nogueira Abreu, Carlos Neandro Cordeiro Lima, Aline Cecy Rocha de Lima, Alexandre do Nascimento Barbosa, Lehi Rodrigues de Oliveira, Mayumi Aragão Fujishima, Sandra Souza Lima, Vitor Nina de Lima, Socorro Castelo-Branco and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Socioecology and Prevalence of SARS-CoV-2 Infection in Quilombolas Living in the Brazilian Amazon.American journal of human biology : the official journal of the Human Biology Council · 2025
    Article
  4. Observational
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hilton Pereira da Silva *Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belem, Brazil.
Isabella Nogueira AbreuSecretaria de Saúde do Município de Belém (SESMA), Belem, Brazil.
Carlos Neandro Cordeiro LimaSecretaria de Saúde do Município de Belém (SESMA), Belem, Brazil.
Aline Cecy Rocha de LimaSecretaria de Saúde do Município de Belém (SESMA), Belem, Brazil.
Alexandre do Nascimento BarbosaFaculdade de Medicina, Instituto de Ciências da Saúde, Universidade Federal do Pará, Belem, Brazil.
Lehi Rodrigues de OliveiraFaculdade de Medicina, Instituto de Ciências da Saúde, Universidade Federal do Pará, Belem, Brazil.
Mayumi Aragão FujishimaFaculdade de Medicina, Instituto de Ciências da Saúde, Universidade Federal do Pará, Belem, Brazil.
Sandra Souza LimaSecretaria de Saúde do Município de Belém (SESMA), Belem, Brazil.
Vitor Nina de LimaPrograma de Pós-Graduação Saúde, Ambiente e Sociedade da Amazônia e Programa de Pós-Graduação em Antropologia, Universidade Federal do Pará, Belem, Brazil.
Socorro Castelo-Branco *Laboratório de Estudos Bioantropológicos em Saúde e Meio Ambiente, Instituto de Filosofia e Ciências Humanas, Universidade Federal do Pará, Belem, Brazil.
Antonio Carlos Rosário Vallinoto *Secretaria de Saúde do Município de Belém (SESMA), Belem, Brazil. vallinoto@ufpa.br.
Universidade Federal do Pará · BRSecretaria da Saúde · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence of the new causative agent of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the city of Wuhan, China, in December 2019, and its spread worldwide, led the World Health Organization (WHO) to declare a pandemic. The disease has caused high mortality among traditional populations and the most socially vulnerable groups such indigenous and refugees. The present study aims to investigate the prevalence of anti-SARS-CoV-2 IgG antibodies in the population of Venezuelan indigenous Warao refugees residing in private and public shelters in the city of Belem, capital of Para State, in the Brazilian Amazon.

methodsOne hundred one individuals of both sexes (43 men and 58 women) with ages varying from 18 to 77 years (average of 36 years) were investigated. Whole blood samples were collected and subsequently separated into plasma and leukocytes. Serological analysis was performed using an enzyme-linked immunosorbent assay - ELISA (Anti-SARS-COV-2 S1 IgG, EUROIMMUN, USA).

resultsThe results indicate a positive serum prevalence of 83.2% (84), of which 77.6% (45/58) were females and 90.7% (39/43) were males. An indeterminate profile was observed in 6.9% (7), where it was not possible to confirm the presence of antibodies, and 9.9% (10) individuals were negative for IgG antibodies.

conclusionsThe finding of the high seroprevalence of IgG anti-SARS-CoV-2 antibodies reveals a high exposure of the Warao population in Belem to infection with the new coronavirus. These results underscore the importance of maintaining epidemiological surveillance with testing in traditional populations due to the high possibility of spreading the virus, especially among the most socioeconomically vulnerable groups, which depend exclusively on the Unified Health System (SUS), such as refugees and indigenous people.

Indexed as

COVID-19RefugeesAdolescentAdultAgedAntibodies, ViralBrazilEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedPandemicsSARS-CoV-2Seroepidemiologic StudiesYoung AdultAntibodies, ViralBrazilIndigenousMigrationSARS-CoV-2Warao

Identifiers

PMID34511064
PMCPMC8435358
OpenAlexW3199690387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.